Functional evaluation of pancreatic islets from patients with Beckwith–Wiedemann syndrome and congenital hyperinsulinism
Open Access
- 15 February 2026
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (7) , 1874-1885
Abstract
Context: Beckwith–Wiedemann Syndrome (BWS) is an overgrowth syndrome caused by various genetic or epigenetic abnormalities in a cluster of imprinted genes on chromosome 11p15. Congenital hyperinsulinism (HI) is one of the cardinal features of BWS, but the pathophysiology of HI in BWS has not been clearly defined. Objective: We describe the islet phenotype of a series of infants with severe HI and comorbid BWS who required pancreatectomy for intractable hypoglycemia. Methods: The cases are a subset of HI patients who required pancreatectomy and had Beckwith–Wiedemann Syndrome. Molecular testing for BWS was performed by SNP array and chromosome 11p15 methylation analysis. Functional analysis of insulin secretion in pancreatic islets isolated from pancreatectomy samples was completed with perifusion experiments and cytosolic Ca2+ measurements. Results: Similar to what we had previously described in islets isolated from the pancreas of infants with HI due to inactivating mutations in the KATP channel, BWS–HI islets have elevated concentrations of cytosolic calcium and secrete insulin in response to stimulation with a physiologic mixture of amino acids. However, unlike KATPHI islets, most BWS–HI islets retain responsiveness to stimulation with glucose and the KATP channel inhibitor glyburide. Through RNAseq analysis, we observed that expression of KCNQ1, encoding the pore-forming subunit of a voltage-gated K + channel (Kv7.1), is reduced in BWS–HI islets compared to normal human islets (3-fold; P = 4.5 × 10-7). Conclusion: Our expression analysis and functional evaluation of islets isolated from BWS–HI patients reveal the spectrum of insulin secretion responses found across BWS etiologies and suggest a potential role for loss of KCNQ1 expression in the complex pathophysiology responsible for the hyperinsulinism in BWS.Keywords
Funding Information
- Norges Idrettshøgskole (R01-DK098517)
This publication has 40 references indexed in Scilit:
- Characterization of the Beckwith‐Wiedemann spectrum: Diagnosis and managementAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2019
- Novel dominant KATP channel mutations in infants with congenital hyperinsulinism: Validation by in vitro expression studies and in vivo carrier phenotypingAmerican Journal of Medical Genetics Part A, 2019
- Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemiaBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- Pancreatic surgery in infants with Beckwith–Wiedemann Syndrome and HyperinsulinismJournal of Pediatric Surgery, 2013
- Bilateral Pheochromocytomas, Hemihyperplasia, and Subtle Somatic Mosaicism: The Importance of Detecting Low‐Level Uniparental DisomyAmerican Journal of Medical Genetics Part A, 2013
- Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11Reviews in Endocrine and Metabolic Disorders, 2010
- Beckwith–Wiedemann syndromeAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2010
- Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by KATP channel mutationsThe Journal of Pediatrics, 2006
- Parental imprinting of the mouse insulin-like growth factor II geneCell, 1991
- Glycemic response to glucagon during fasting hypoglycemia: An aid in the diagnosis of hyperinsulinismThe Journal of Pediatrics, 1980